Aliases & Classifications for Migraine with Aura

MalaCards integrated aliases for Migraine with Aura:

Name: Migraine with Aura 12 28 41 14 69
Migraine with Typical Aura 69
Classic Migraine 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10024
ICD9CM 34 346.0
MeSH 41 D020325
NCIt 46 C117005
SNOMED-CT 64 155047002 4473006

Summaries for Migraine with Aura

Disease Ontology : 12 A migraine characterized by migraine headache which is preceded or accompanied by a transient focal neurological phenomenon.

MalaCards based summary : Migraine with Aura, also known as migraine with typical aura, is related to familial hemiplegic migraine and hemiplegic migraine, and has symptoms including headache An important gene associated with Migraine with Aura is MGR7 (Migraine With Aura, Susceptibility To, 7), and among its related pathways/superpathways are cAMP signaling pathway and Calcium signaling pathway. The drugs Milnacipran and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include brain, endothelial and cortex, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Related Diseases for Migraine with Aura

Diseases in the Migraine with Aura family:

Migraine with Aura 7 Migraine with Aura 9

Diseases related to Migraine with Aura via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 126)
# Related Disease Score Top Affiliating Genes
1 familial hemiplegic migraine 32.3 ATP1A2 CACNA1A NOTCH3 SCN1A
2 hemiplegic migraine 31.9 ATP1A2 CACNA1A NOTCH3 PRRT2 SCN1A
3 headache 30.7 ATP1A2 CACNA1A EDNRA KCNK18 SCN1A
4 familial or sporadic hemiplegic migraine 30.7 ATP1A2 CACNA1A PRRT2 SCN1A
5 sporadic hemiplegic migraine 30.4 ATP1A2 CACNA1A SCN1A
6 migraine without aura 30.4 ATP1A2 CACNA1A DRD2 KCNK18 MTHFR SCN1A
7 restless legs syndrome 29.9 CACNA1A DRD2 SLC6A3
8 ischemic optic neuropathy 29.7 ACE MTHFR NOS3
9 cerebrovascular disease 29.4 ACE MTHFR NOTCH3
10 anxiety 29.1 HTR2C SLC6A3 SLC6A4
11 migraine with or without aura 1 28.7 ATP1A2 CACNA1A DBH DRD2 EDNRA HTR1B
12 migraine with aura 7 12.2
13 migraine with aura 9 12.2
14 epilepsy, familial temporal lobe, 4 11.4
15 migraine, familial hemiplegic, 1 11.2
16 migraine, familial hemiplegic, 2 11.2
17 migraine, familial hemiplegic, 3 11.1
18 migraine with or without aura 13 11.1
19 cerebritis 10.4
20 alcohol use disorder 10.4 DRD2 SLC6A4
21 hemiplegia 10.4 ATP1A2 CACNA1A SCN1A
22 patent foramen ovale 10.3
23 psychosexual disorder 10.3 HTR2C SLC6A4
24 periodic limb movement disorder 10.3 DRD2 HTR2C SLC6A4
25 torticollis 10.2 CACNA1A DRD2 PRRT2
26 early-onset schizophrenia 10.2 DBH DRD2 SLC6A4
27 hemifacial spasm 10.2 MTHFR NOS3
28 episodic pain syndrome, familial, 1 10.2
29 atrial heart septal defect 10.2
30 cerebral atherosclerosis 10.2 ACE MTHFR
31 episodic ataxia 10.2 ATP1A2 CACNA1A PRRT2
32 arteriovenous malformation 10.1
33 endotheliitis 10.1
34 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 10.1
35 renal artery disease 10.0 ACE NOS3
36 vascular dementia 10.0 ACE MTHFR NOTCH3
37 brunner syndrome 10.0 DBH HTR1B SLC6A4
38 prinzmetal's variant angina 10.0 HTR1B NOS3
39 borderline personality disorder 10.0 HTR1B HTR2C SLC6A4
40 thrombophilia 10.0
41 cervicitis 10.0
42 cluster headache 10.0
43 hemicrania continua 10.0
44 aneurysm 10.0
45 ischemic heart disease 10.0 ACE MTHFR NOS3
46 arteritic anterior ischemic optic neuropathy 10.0 ACE MTHFR NOS3
47 nonarteritic anterior ischemic optic neuropathy 9.9 ACE MTHFR NOS3
48 mitral valve disease 9.9 ACE NOS3 SLC6A4
49 alcohol-induced mental disorder 9.9 DRD2 SLC6A3 SLC6A4
50 alcoholic psychosis 9.9 DRD2 SLC6A3 SLC6A4

Comorbidity relations with Migraine with Aura via Phenotypic Disease Network (PDN):


Hypertension, Essential Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Migraine with Aura:



Diseases related to Migraine with Aura

Symptoms & Phenotypes for Migraine with Aura

UMLS symptoms related to Migraine with Aura:


headache

GenomeRNAi Phenotypes related to Migraine with Aura according to GeneCards Suite gene sharing:

25 (show all 20)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-139 9.74 SLC6A4
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-142 9.74 INSR
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-153 9.74 MTHFR
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-173 9.74 MTHFR
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-18 9.74 INSR
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-180 9.74 MTHFR
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-187 9.74 SLC6A4
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-195 9.74 ATP1A2
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-200 9.74 ATP1A2
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-213 9.74 INSR
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-33 9.74 MTHFR
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-34 9.74 ATP1A2
13 Decreased shRNA abundance (Z-score < -2) GR00366-A-40 9.74 ATP1A2 INSR SLC6A4
14 Decreased shRNA abundance (Z-score < -2) GR00366-A-60 9.74 INSR
15 Decreased shRNA abundance (Z-score < -2) GR00366-A-68 9.74 ATP1A2 INSR MTHFR SLC6A4
16 Decreased shRNA abundance (Z-score < -2) GR00366-A-71 9.74 SLC6A4
17 Decreased shRNA abundance (Z-score < -2) GR00366-A-77 9.74 MTHFR
18 Decreased shRNA abundance (Z-score < -2) GR00366-A-86 9.74 MTHFR
19 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 9.74 MTHFR SLC6A4
20 Decreased shRNA abundance (Z-score < -2) GR00366-A-95 9.74 MTHFR

MGI Mouse Phenotypes related to Migraine with Aura:

43 (show all 14)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.4 INSR HTR1B NOS3 HTR2C SLC6A3 NOTCH3
2 growth/size/body region MP:0005378 10.32 EDNRA INSR HTR1B MTHFR NOS3 HTR2C
3 mortality/aging MP:0010768 10.28 EDNRA INSR HTR1B MTHFR NOS3 HTR2C
4 homeostasis/metabolism MP:0005376 10.27 NOS3 INSR EDNRA MTHFR HTR2C SLC6A3
5 cardiovascular system MP:0005385 10.25 NOS3 INSR EDNRA HTR1B SCN1A NOTCH3
6 endocrine/exocrine gland MP:0005379 10.24 EDNRA INSR HTR1B NOS3 SLC6A3 NOTCH3
7 nervous system MP:0003631 10.2 INSR KCNK18 MTHFR NOS3 HTR2C SLC6A3
8 integument MP:0010771 10.13 EDNRA MTHFR HTR2C SLC6A3 NOTCH3 SLC6A4
9 muscle MP:0005369 10.11 INSR HTR1B NOS3 HTR2C SLC6A3 NOTCH3
10 adipose tissue MP:0005375 10.08 HTR2C INSR HTR1B NOS3 ACE DBH
11 normal MP:0002873 9.96 NOS3 EDNRA SLC6A3 NOTCH3 SLC6A4 SCN1A
12 reproductive system MP:0005389 9.9 INSR KCNK18 HTR1B MTHFR NOS3 SLC6A3
13 respiratory system MP:0005388 9.5 INSR EDNRA NOS3 NOTCH3 CACNA1A ATP1A2
14 skeleton MP:0005390 9.28 EDNRA MTHFR HTR1B NOS3 SLC6A3 NOTCH3

Drugs & Therapeutics for Migraine with Aura

Drugs for Migraine with Aura (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 132)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Milnacipran Approved, Investigational Phase 4 92623-85-3 65833
2
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
3
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
4
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
5
Almotriptan Approved, Investigational Phase 4 154323-57-6, 181183-52-8 123606
6
Topiramate Approved Phase 4,Phase 3,Phase 2 97240-79-4 5284627
7
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
8 Adrenergic Agents Phase 4,Phase 2,Phase 3
9 Antidepressive Agents Phase 4
10 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
11 Neurotransmitter Uptake Inhibitors Phase 4
12 Psychotropic Drugs Phase 4,Phase 2
13
Serotonin Phase 4,Phase 3,Phase 2 50-67-9 5202
14 Serotonin Agents Phase 4,Phase 3,Phase 2
15 Serotonin Uptake Inhibitors Phase 4
16 Analgesics Phase 4,Phase 2,Phase 3
17 Analgesics, Non-Narcotic Phase 4,Phase 2
18 Anti-Inflammatory Agents Phase 4,Phase 1,Phase 2
19 Anti-Inflammatory Agents, Non-Steroidal Phase 4
20 Antirheumatic Agents Phase 4
21 Cyclooxygenase Inhibitors Phase 4
22 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
23 Antiemetics Phase 4,Phase 3,Phase 1,Phase 2
24 Autonomic Agents Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
25 Dopamine Agents Phase 4
26 Dopamine Antagonists Phase 4
27 Dopamine D2 Receptor Antagonists Phase 4
28 Gastrointestinal Agents Phase 4,Phase 3,Phase 1,Phase 2
29 Ketorolac Tromethamine Phase 4
30 Anticonvulsants Phase 4,Phase 3,Phase 2
31 Anti-Obesity Agents Phase 4,Phase 3,Phase 2
32 Neuroprotective Agents Phase 4,Phase 3,Phase 2,Early Phase 1
33 Protective Agents Phase 4,Phase 3,Phase 2,Early Phase 1
34 Adjuvants, Anesthesia Phase 4
35 Analgesics, Opioid Phase 4
36 Anesthetics Phase 4,Phase 3,Phase 1,Phase 2
37 Anesthetics, General Phase 4
38 Anesthetics, Intravenous Phase 4
39 Central Nervous System Depressants Phase 4,Phase 3,Phase 1,Phase 2
40 Narcotics Phase 4
41 Pharmaceutical Solutions Phase 4
42
Sumatriptan Approved, Investigational Phase 3,Phase 2 103628-46-2 5358
43
Diphenhydramine Approved, Investigational Phase 3 58-73-1, 147-24-0 3100
44
Histamine Approved, Investigational Phase 3 51-45-6, 75614-87-8 774
45
Promethazine Approved, Investigational Phase 3 60-87-7 4927
46
Eletriptan Approved, Investigational Phase 3 143322-58-1 77993
47
Rizatriptan Approved Phase 3 144034-80-0, 145202-66-0 5078
48
Angiotensin II Approved, Investigational Phase 2, Phase 3 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
49
Propranolol Approved, Investigational Phase 2, Phase 3 525-66-6 4946
50
Caffeine Approved, Nutraceutical Phase 3 58-08-2 2519

Interventional clinical trials:

(show top 50) (show all 65)

# Name Status NCT ID Phase Drugs
1 Preventive Treatment of Episodic and Chronic Migraine Unknown status NCT01319825 Phase 4 milnacipran
2 Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department Completed NCT01596166 Phase 4 Ketorolac Tromethamine;Metoclopramide
3 Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine Completed NCT00210496 Phase 4 topiramate; almotriptan malate
4 Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache. Completed NCT00212810 Phase 4 Topiramate
5 Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial Completed NCT02314351 Phase 4 Metoclopramide 10 mg;Placebo;Fentanyl
6 Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura Completed NCT00449540 Phase 3
7 Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment Completed NCT01814189 Phase 3 Sumatriptan+Promethazine (SPr)
8 Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine Completed NCT01741714 Phase 3
9 Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study Completed NCT01859481 Phase 3 Placebo;Eletriptan HBr 40 mg;Eletriptan HBr 80 mg
10 Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine Completed NCT00334178 Phase 3 Laxymig ER (drug)
11 Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache Completed NCT00471952 Phase 3 Maxalt 10mg MLT plus Caffeine 75mg;Maxalt 10mg MLT plus Placebo;Placebo + Placebo
12 Candesartan Versus Propranolol for Migraine Prevention Completed NCT00884663 Phase 2, Phase 3 Candesartan;propranolol;placebo
13 A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine Completed NCT00236509 Phase 3 topiramate
14 A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine Completed NCT00236561 Phase 3 topiramate, propranolol
15 A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine Completed NCT00231595 Phase 3 topiramate
16 Oral ALLOD-2 vs. Its Components & vs. Placebo in the Acute Treatment of Migraine (ANODYNE-1) Completed NCT03061734 Phase 2, Phase 3 ALLOD-2;ALLOD-2H;Component A (regular dose);Component B;Placebo
17 Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine Completed NCT00131443 Phase 2, Phase 3 Topiramate
18 Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura Unknown status NCT00877838 Phase 2 NXN-188;Placebo
19 Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine Unknown status NCT00285402 Phase 2 AST-726 Low dose;AST-726 High dose;AST-726 Placebo
20 Tonabersat in the Prophylaxis of Migraine With Aura Completed NCT00332007 Phase 2 Tonabersat;Placebo
21 Study of NXN 188 for the Treatment of Migraine With Aura Completed NCT00920686 Phase 2 NXN-188;placebo;sumatriptan succinate
22 Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache Completed NCT00123201 Phase 2 Dronabinol MDI
23 Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Completed NCT00534560 Phase 2 Tonabersat;Tonabersat;Placebo
24 Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Completed NCT00311662 Phase 2 Tonabersat;Placebo
25 A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine Completed NCT00158002 Phase 2 Topiramate
26 Botox Injection in Treatment of Chronic Migraine Completed NCT02259075 Phase 1, Phase 2 Botulinum Toxin Type A
27 Treatment of Chronic Migraine Headaches. Recruiting NCT03220113 Phase 1, Phase 2
28 PRIMA PFO Migraine Trial Terminated NCT00505570 Phase 2
29 A Study of a Melatonin Receptor Agonist to Prevent Migraine Terminated NCT00739024 Phase 2 Ramelteon;Placebo
30 Efficacy of Sumatriptan With Naprosyn in Migraine With Aura Unknown status NCT00893594 sumatriptan with naprosyn;placebo
31 Functional MRI and MRA in Migraine With Aura Unknown status NCT01388894
32 Migraine and Endothelial Dysfunction Unknown status NCT01388699
33 Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI Unknown status NCT02202486
34 MIBRAIN - Migraine and the Brain: Consequences, Causes, and Vascular Interaction Unknown status NCT01803984
35 Retinal Nerve Fiber Layer Thickness Changes in Migraine: A Meta-Analysis of Case-control Studies Unknown status NCT02196532
36 Inflammatory Markers Identification in Migraine Patients Unknown status NCT01618201
37 Identification of Inflammatory Markers in Migraine Patients Unknown status NCT00969995
38 Brainstem Grey Matter and Cerebral Autoregulation in Migraine With Aura. Completed NCT02708797
39 Women With Migraine With Aura Neuroimaging Study Completed NCT02047695
40 Induction of Migraine Aura With Cilostazol Completed NCT02253004 Early Phase 1 Cilostazol;Placebo
41 Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA) Completed NCT00687947 CGRP
42 Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia Completed NCT01896167
43 Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP) Completed NCT01257880
44 Transcriptomic and Biochemical Changes During a Migraine Attack Completed NCT02468622
45 Impact of a Nurse for Migraine Management: the IMPACT Project Completed NCT01804517
46 Impact of tDCS on Cerebral Autoregulation Completed NCT01865604
47 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice Completed NCT02115269
48 Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Completed NCT00541736 Nitroglycerine
49 Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine Completed NCT01828684
50 Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura Completed NCT00126035

Search NIH Clinical Center for Migraine with Aura

Cochrane evidence based reviews: migraine with aura

Genetic Tests for Migraine with Aura

Genetic tests related to Migraine with Aura:

# Genetic test Affiliating Genes
1 Migraine with Aura 28

Anatomical Context for Migraine with Aura

MalaCards organs/tissues related to Migraine with Aura:

38
Brain, Endothelial, Cortex, Testes, Bone, Heart, Pituitary

Publications for Migraine with Aura

Articles related to Migraine with Aura:

(show top 50) (show all 370)
# Title Authors Year
1
Migraine with aura and persistent foramen ovale. ( 29219954 )
2018
2
Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura. ( 28430860 )
2017
3
Migraine with aura and white matter lesions: an MRI study. ( 28527087 )
2017
4
Pediatric migraine with aura in an Italian case series. ( 28527089 )
2017
5
Aspirin Prophylaxis for Migraine with Aura: An Observational Case Series. ( 29017164 )
2017
6
Prospective testing of ICHD-3 beta diagnostic criteria for migraine with aura and migraine with typical aura in patients with transient ischemic attacks. ( 28372496 )
2017
7
Recognizing CADASIL: a Secondary Cause of Migraine with Aura. ( 28281108 )
2017
8
Evidence for Plastic Processes in Migraine with Aura: A Diffusion Weighted MRI Study. ( 29387002 )
2017
9
Increased intrinsic brain connectivity between pons and somatosensory cortex during attacks of migraine with aura. ( 28240389 )
2017
10
A randomized controlled trial of acupressure as an adjunctive therapy to sodium valproate on the prevention of chronic migraine with aura. ( 28682918 )
2017
11
A Case of Migraine With Aura Resolving on Warfarin But Not on Apixaban. ( 28960288 )
2017
12
Effect of hypoxia on BOLD fMRI response and total cerebral blood flow in migraine with aura patients. ( 28686073 )
2017
13
Foveal and Peripapillary Vascular Decrement in Migraine With Aura Demonstrated by Optical Coherence Tomography Angiography. ( 29059314 )
2017
14
Migraine with Aura or Sports-Related Concussion: Case Report, Pathophysiology, and Multidisciplinary Approach to Management. ( 28067735 )
2017
15
Migraine with aura white matter lesions: preliminary data on clinical aspects. ( 28527065 )
2017
16
Magnetic resonance imaging in children presenting migraine with aura: Association of hypoperfusion detected by arterial spin labelling and vasospasm on MR angiography findings. ( 28738690 )
2017
17
Migraine with aura and screening for biologicalA thrombophilia. ( 29175257 )
2017
18
Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura. ( 28994605 )
2017
19
A Review of "Hormonal Contraceptives and Migraine With Aura - Is There Still a Risk?" ( 28128464 )
2017
20
Relationship between primary restless legs syndrome and migraine with aura. ( 27523456 )
2016
21
Rare Complications of Migraine With Aura. ( 27400397 )
2016
22
High leptin levels are associated with migraine with aura. ( 27165492 )
2016
23
White matter lesion burden in migraine with aura may be associated with reduced cerebral blood flow. ( 27177583 )
2016
24
Addenbrooke's cognitive examination test for brief cognitive assessment of adolescents suffering from migraine with aura. ( 27255917 )
2016
25
Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. ( 26908949 )
2016
26
Stromal Cell-Derived Factor-1 Alpha Is Decreased in Women With Migraine With Aura. ( 27238143 )
2016
27
De Novo Migraine With Aura After Surgical Repair of Aortic Coarctation. ( 27910096 )
2016
28
The effect of 1A mg folic acid supplementation on clinical outcomes in female migraine with aura patients. ( 27339806 )
2016
29
Transient Splenial Lesion of the Corpus Callosum Related to Migraine with Aura in a Pediatric Patient. ( 27526308 )
2016
30
Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study. ( 27930349 )
2016
31
Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI study. ( 27190013 )
2016
32
Can the border of migraine with aura be safely extended? ( 27152015 )
2016
33
Frequency of pediatric migraine with aura in a clinic-based sample. ( 26790850 )
2016
34
Hormonal Contraceptives and Migraine With Aura-Is There Still a Risk? ( 27774589 )
2016
35
Visual Snow in Migraine With Aura: Further Characterization by Brain Imaging, Electrophysiology, and Treatment - Case Report. ( 26307008 )
2015
36
Abnormal Connectivity Within Executive Resting-State Network in Migraine With Aura. ( 26084236 )
2015
37
Migraine with aura and patent foramen ovale: myth or reality? ( 26017514 )
2015
38
Reduced efficacy of sumatriptan in migraine with aura vs without aura. ( 25841032 )
2015
39
Investigations of functional and structural changes in migraine with aura by magnetic resonance imaging. ( 26239598 )
2015
40
No abnormalities of intrinsic brain connectivity in the interictal phase of migraine with aura. ( 25573335 )
2015
41
Migraine with aura and TCD bubble-test: The significance of positive result. ( 26495697 )
2015
42
Vitamin Supplementation as Possible Prophylactic Treatment against Migraine with Aura and Menstrual Migraine. ( 25815319 )
2015
43
Incidences of aortic and mitral valve strands in patients with migraine with aura. ( 25936701 )
2015
44
Recurrence of Migraine With Aura After a 24-year Free Period Following rTMS Treatment for Fibromyalgia Pain. ( 26358488 )
2015
45
Migraine with aura: which patients are most at risk of stroke? ( 26017513 )
2015
46
Cortical hot spots and labyrinths: why cortical neuromodulation for episodic migraine with aura should be personalized. ( 25798103 )
2015
47
O021. Abnormal connectivity within executive resting-state network in migraine with aura. ( 28132232 )
2015
48
Efficacy of frovatriptan as compared to other triptans in migraine with aura. ( 25916333 )
2015
49
P066. Migraine with aura in the locker room: 4 case reports. ( 28132219 )
2015
50
Statins for all: should patients who have migraine with aura be on a statin? ( 26500300 )
2015

Variations for Migraine with Aura

Expression for Migraine with Aura

Search GEO for disease gene expression data for Migraine with Aura.

Pathways for Migraine with Aura

GO Terms for Migraine with Aura

Cellular components related to Migraine with Aura according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of plasma membrane GO:0005887 9.86 DRD2 EDNRA HTR1B HTR2C INSR KCNK18
2 integral component of membrane GO:0016021 9.83 ACE ATP1A2 CACNA1A DBH DRD2 EDNRA
3 presynapse GO:0098793 9.54 CACNA1A SLC6A3 SLC6A4
4 caveola GO:0005901 9.5 ATP1A2 INSR NOS3
5 plasma membrane GO:0005886 9.5 ACE ATP1A2 CACNA1A DRD2 EDNRA HTR1B
6 membrane GO:0016020 10.06 ACE ATP1A2 CACNA1A DBH DRD2 EDNRA

Biological processes related to Migraine with Aura according to GeneCards Suite gene sharing:

(show all 33)
# Name GO ID Score Top Affiliating Genes
1 chemical synaptic transmission GO:0007268 9.88 CACNA1A DBH HTR1B HTR2C
2 response to ethanol GO:0045471 9.82 DRD2 HTR1B SLC6A3
3 glucose homeostasis GO:0042593 9.81 CACNA1A DBH INSR
4 response to hypoxia GO:0001666 9.8 DRD2 EDNRA MTHFR SLC6A4
5 memory GO:0007613 9.71 DBH INSR SLC6A4
6 response to iron ion GO:0010039 9.66 DRD2 SLC6A3
7 response to pain GO:0048265 9.65 CACNA1A DBH
8 regulation of sodium ion transport GO:0002028 9.65 DRD2 NOS3
9 visual learning GO:0008542 9.65 ATP1A2 DBH DRD2
10 negative regulation of cAMP biosynthetic process GO:0030818 9.64 EDNRA HTR1B
11 negative regulation of cytosolic calcium ion concentration GO:0051481 9.63 ATP1A2 DRD2
12 behavioral response to ethanol GO:0048149 9.63 DBH DRD2
13 feeding behavior GO:0007631 9.63 DRD2 HTR1B HTR2C
14 negative regulation of synaptic transmission, glutamatergic GO:0051967 9.62 DRD2 HTR1B
15 neurotransmitter biosynthetic process GO:0042136 9.62 SLC6A3 SLC6A4
16 ammonium transmembrane transport GO:0072488 9.61 SLC6A3 SLC6A4
17 prepulse inhibition GO:0060134 9.61 DRD2 SLC6A3
18 response to nicotine GO:0035094 9.61 ATP1A2 DRD2 SLC6A3
19 neuromuscular process controlling posture GO:0050884 9.6 PRRT2 SCN1A
20 G-protein coupled receptor internalization GO:0002031 9.59 DRD2 HTR1B
21 behavior GO:0007610 9.58 HTR1B HTR2C
22 response to cocaine GO:0042220 9.58 DRD2 HTR1B SLC6A3
23 adenohypophysis development GO:0021984 9.57 DRD2 SLC6A3
24 neuron-neuron synaptic transmission GO:0007270 9.56 CACNA1A DRD2
25 locomotory behavior GO:0007626 9.56 DBH DRD2 HTR2C SLC6A3
26 monoamine transport GO:0015844 9.55 SLC6A3 SLC6A4
27 blood vessel remodeling GO:0001974 9.54 ACE DBH NOS3
28 dopamine catabolic process GO:0042420 9.52 DBH SLC6A3
29 dopamine uptake involved in synaptic transmission GO:0051583 9.51 SLC6A3 SLC6A4
30 adult walking behavior GO:0007628 9.5 CACNA1A DRD2 SCN1A
31 vasoconstriction GO:0042310 9.33 EDNRA HTR1B SLC6A4
32 regulation of blood pressure GO:0008217 9.26 ACE ATP1A2 EDNRA NOS3
33 response to drug GO:0042493 9.1 DRD2 HTR1B HTR2C MTHFR SLC6A3 SLC6A4

Molecular functions related to Migraine with Aura according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neurotransmitter:sodium symporter activity GO:0005328 9.37 SLC6A3 SLC6A4
2 dopamine binding GO:0035240 9.32 DRD2 SLC6A3
3 serotonin binding GO:0051378 9.26 HTR1B HTR2C
4 monoamine transmembrane transporter activity GO:0008504 9.16 SLC6A3 SLC6A4
5 drug binding GO:0008144 9.1 ACE ATP1A2 DRD2 HTR1B HTR2C SLC6A3
6 dopamine:sodium symporter activity GO:0005330 8.96 SLC6A3 SLC6A4

Sources for Migraine with Aura

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....